Life Science Group Ltd (LSG) is
delighted to be able to partake in the NHS Lateral Flow Pilot Study. LSG
will be proactively testing all staff twice weekly using the Innova Covid-19 Lateral Flow test.
LSG will also be testing
any visitors onto the site.
LSG has been working since April
2020 to supply consumables in to the DHSC Test and Trace program.
Lateral Flow tests are being
widely rolled out across the country and will be an important tool in
identifying infections people. However, it must be stressed that Lateral
Flow tests have not been developed to replace current PCR testing for
diagnosis.
Lateral Flow tests are idea for testing large groups of people
to identify those individuals who are asymptomatic of the disease but capable
of spreading virus and those who are actively infectious and who are therefore
likely to spread the infection.
Rapid identification and isolation of
these individuals will enable the disease to be quickly contained and ‘at risk’
contacts quickly identified through the Track and Trace system.
created with
WordPress Page Builder .